{"id":39752,"date":"2026-08-10T20:03:03","date_gmt":"2026-08-10T19:03:03","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=39752"},"modified":"2026-08-10T20:03:03","modified_gmt":"2026-08-10T19:03:03","slug":"birlesik-krallik-yeni-zayiflama-hapini-onayladi","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/birlesik-krallik-yeni-zayiflama-hapini-onayladi\/","title":{"rendered":"Birle\u015fik Krall\u0131k yeni zay\u0131flama hap\u0131n\u0131 onaylad\u0131"},"content":{"rendered":"<p>Birle\u015fik Krall\u0131k, <strong>Eli Lilly<\/strong> taraf\u0131ndan geli\u015ftirilen g\u00fcnl\u00fck zay\u0131flama hap\u0131 <strong>Foundayo\u2019ya<\/strong> kullan\u0131m onay\u0131 veren Avrupa\u2019daki ilk \u00fclke oldu. \u0130la\u00e7, obezitenin yan\u0131 s\u0131ra tip 2 diyabet tedavisinde kullan\u0131labilecek.<\/p>\n<p>\u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri D\u00fczenleme Kurumu\u2019nun (MHRA) verdi\u011fi onay, Foundayo\u2019nun re\u00e7eteyle \u00f6zel olarak temin edilebilmesinin \u00f6n\u00fcn\u00fc a\u00e7t\u0131. Ancak karar, ilac\u0131n kilo verme tedavisi kapsam\u0131nda otomatik olarak <strong>NHS<\/strong> \u00fczerinden sunulaca\u011f\u0131 anlam\u0131na gelmiyor.<\/p>\n<h4>NHS i\u00e7in ayr\u0131 de\u011ferlendirme yap\u0131lacak<\/h4>\n<p>BBC&#8217;nin haberine g\u00f6re Mounjaro enjeksiyonunun da \u00fcreticisi olan Eli Lilly, Foundayo\u2019nun tip 2 diyabet tedavisinde NHS taraf\u0131ndan kullan\u0131labilece\u011fini bildirdi. \u015eirket, ilac\u0131n kilo verme tedavisinde de tavsiye edilmesi i\u00e7in \u0130ngiltere Ulusal Sa\u011fl\u0131k ve Bak\u0131m M\u00fckemmelli\u011fi Enstit\u00fcs\u00fc\u2019ne (NICE) ba\u015fvuraca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/p><div id=\"briti-1971725568\" class=\"briti-icerik\" style=\"margin-top: 5px;margin-bottom: 5px;\"><a href=\"https:\/\/piaryum.com\/services\/\" aria-label=\"piaryum banner\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/by-tv.co.uk\/wp-content\/uploads\/2025\/12\/Gemini_Generated_Image_g5yqr1g5yqr1g5yq.jpg\" alt=\"\"  width=\"2064\" height=\"1152\"   \/><\/a><\/div>\n<p><strong>Orforglipron<\/strong> olarak da bilinen Foundayo, i\u015ftah\u0131 azaltmaya yard\u0131mc\u0131 olan GLP-1 s\u0131n\u0131f\u0131 ila\u00e7lar aras\u0131nda yer al\u0131yor. MHRA, haziran ay\u0131nda benzer bir kilo verme ilac\u0131 olan Wegovy\u2019nin tablet formunu da onaylam\u0131\u015ft\u0131.<\/p>\n<h4>Uzmanlar maliyet ve kullan\u0131m kolayl\u0131\u011f\u0131na dikkat \u00e7ekti<\/h4>\n<p>BBCAnglia Ruskin \u00dcniversitesi\u2019nden Dr. Simon Cork, Foundayo ile sa\u011flanan kilo kayb\u0131n\u0131n baz\u0131 di\u011fer tedavilere k\u0131yasla daha d\u00fc\u015f\u00fck oldu\u011funu, ancak hastalarda yine de <strong>\u201cklinik a\u00e7\u0131dan anlaml\u0131\u201d kilo de\u011fi\u015fimleri<\/strong> g\u00f6r\u00fclebilece\u011fini belirtti. Cork, ilac\u0131n mevcut baz\u0131 kilo verme tedavilerinden daha d\u00fc\u015f\u00fck maliyetli olmas\u0131n\u0131n \u00f6nemli bir avantaj sa\u011flayabilece\u011fini ifade etti.<\/p>\n<p>Glasgow \u00dcniversitesi\u2019nden Prof. Naveed Sattar da geli\u015fmeyi olumlu de\u011ferlendirerek ilac\u0131n kullan\u0131m kolayl\u0131\u011f\u0131na dikkat \u00e7ekti. Sattar, a\u00e7 karn\u0131na al\u0131nmas\u0131 gereken Wegovy tabletinin aksine Foundayo\u2019nun g\u00fcn\u00fcn herhangi bir saatinde kullan\u0131labildi\u011fini belirtti.<\/p>\n<h4>Kilo kayb\u0131n\u0131n korunmas\u0131na yard\u0131mc\u0131 olabilir<\/h4>\n<p>Klinik ara\u015ft\u0131rmalar, daha \u00f6nce kilo verme i\u011fneleri kullanan ve ard\u0131ndan bir y\u0131l boyunca g\u00fcnl\u00fck orforglipron alan ki\u015filerin, kaybettikleri kilolar\u0131n \u00f6nemli b\u00f6l\u00fcm\u00fcn\u00fc geri almaktan ka\u00e7\u0131nabildi\u011fini g\u00f6sterdi. Bu sonu\u00e7, GLP-1 enjeksiyonlar\u0131n\u0131n b\u0131rak\u0131lmas\u0131n\u0131n ard\u0131ndan g\u00f6r\u00fclebilen kilo art\u0131\u015f\u0131n\u0131n \u00f6nlenmesinde ilac\u0131n potansiyel bir rol oynayabilece\u011fine i\u015faret ediyor.<\/p>\n<p>Uzmanlar, kilo verme ila\u00e7lar\u0131n\u0131n sa\u011fl\u0131kl\u0131 beslenme ve yeterli fiziksel aktiviteyle birlikte kullan\u0131lmas\u0131 gerekti\u011fini vurguluyor. Foundayo\u2019nun olas\u0131 yan etkileri aras\u0131nda <strong>bulant\u0131, ishal, kab\u0131zl\u0131k ve kusma<\/strong> bulunuyor.<\/p>\n<div id=\"briti-2980233801\" class=\"briti-icerikten-sonra_2\" style=\"margin-top: 25px;margin-bottom: 25px;\"><a href=\"https:\/\/wa.me\/message\/NDZLLIOQT4H3O1\" aria-label=\"bytv reklam banner\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/by-tv.co.uk\/wp-content\/uploads\/2025\/12\/bytv-reklam-banner.jpg\" alt=\"\"  width=\"2376\" height=\"1008\"   \/><\/a><\/div>","protected":false},"excerpt":{"rendered":"<p>Birle\u015fik Krall\u0131k, Eli Lilly taraf\u0131ndan geli\u015ftirilen g\u00fcnl\u00fck zay\u0131flama hap\u0131 Foundayo\u2019ya kullan\u0131m onay\u0131 veren Avrupa\u2019daki ilk \u00fclke oldu. \u0130la\u00e7, obezitenin yan\u0131 s\u0131ra tip 2 diyabet tedavisinde kullan\u0131labilecek. \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri D\u00fczenleme Kurumu\u2019nun (MHRA) verdi\u011fi onay, Foundayo\u2019nun re\u00e7eteyle \u00f6zel olarak temin edilebilmesinin \u00f6n\u00fcn\u00fc a\u00e7t\u0131. Ancak karar, ilac\u0131n kilo verme tedavisi kapsam\u0131nda otomatik olarak NHS \u00fczerinden sunulaca\u011f\u0131 anlam\u0131na gelmiyor. NHS i\u00e7in ayr\u0131 de\u011ferlendirme yap\u0131lacak BBC&#8217;nin haberine g\u00f6re Mounjaro enjeksiyonunun da \u00fcreticisi olan Eli Lilly, Foundayo\u2019nun tip 2 diyabet tedavisinde NHS taraf\u0131ndan kullan\u0131labilece\u011fini bildirdi. \u015eirket, ilac\u0131n kilo verme tedavisinde de tavsiye edilmesi i\u00e7in \u0130ngiltere Ulusal Sa\u011fl\u0131k ve Bak\u0131m M\u00fckemmelli\u011fi Enstit\u00fcs\u00fc\u2019ne (NICE) ba\u015fvuraca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":39753,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[5269],"tags":[],"class_list":["post-39752","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-birlesik-krallik"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/39752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=39752"}],"version-history":[{"count":1,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/39752\/revisions"}],"predecessor-version":[{"id":39754,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/39752\/revisions\/39754"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media\/39753"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=39752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=39752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=39752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}